| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Review Article |
1 From the Departments of Clinical Medicine (MM, GG, and FRF) and Cell Biology and Hematology (SC and API), University ‘La Sapienza’ Rome.
Bone marrow transplantation (BMT) is a sophisticated procedure consisting of the administration of high-dose chemoradiotherapy followed by intravenous infusion of hemopoietic stem cells to reestablish marrow function when bone marrow is damaged or defective. BMT is used in the treatment of solid tumors, hematologic diseases, and autoimmune disorders. Artificial nutrition, total parenteral nutrition in particular, is provided to patients undergoing BMT to minimize the nutritional consequences of both the conditioning regimens (eg, mucositis of the gastrointestinal tract) and complications resulting from the procedure (eg, graft versus host disease and venoocclusive disease of the liver). Although artificial nutrition is now recognized as the standard of care for BMT patients, defined guidelines for the use of artificial nutrition in this clinical setting are lacking. During the past 2 decades, artificial nutrition in BMT patients has moved from simple supportive care to adjunctive therapy because of the possible benefits, not strictly nutritional, of specialized nutritional intervention. Although data exist documenting the beneficial role of special nutrients, such as lipids and glutamine, in the management of BMT recipients, the results obtained to date are controversial. The reasons for this controversy may reside in the heterogeneity of the patients studied and of the study designs. This review focuses on the need to correctly identify the different patterns of BMT to achieve reproducible and reliable data, which may in turn be used to devise precise guidelines for the use of specialized artificial nutrition in BMT patients.
Key Words: Artificial nutrition • bone marrow transplantation • glutamine • fatty acids
This article has been cited by other articles:
|
|
 |
|
  N. Boukhettala, J. Leblond, S. Claeyssens, M. Faure, F. Le Pessot, C. Bole-Feysot, A. Hassan, C. Mettraux, J. Vuichoud, A. Lavoinne, et al. Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E182 - E190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rodgers and T. Walsh Nutritional Issues in Adolescents After Bone Marrow Transplant: A Literature Review Journal of Pediatric Oncology Nursing, September 1, 2008; 25(5): 254 - 264. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Duro, L. J. Bechard, H. A. Feldman, A. Klykov, A. O'Leary, E. C. Guinan, and C. Duggan Weekly Measurements Accurately Represent Trends in Resting Energy Expenditure in Children Undergoing Hematopoietic Stem Cell Transplantation JPEN J Parenter Enteral Nutr, July 1, 2008; 32(4): 427 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Cereda, M. Turrini, D. Ciapanna, L. Marbello, A. Pietrobelli, and E. Corradi Assessing Energy Expenditure in Cancer Patients: A Pilot Validation of a New Wearable Device JPEN J Parenter Enteral Nutr, November 1, 2007; 31(6): 502 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Bechard, E. C. Guinan, H. A. Feldman, V. Tang, and C. Duggan Prognostic Factors in the Resumption of Oral Dietary Intake After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Children JPEN J Parenter Enteral Nutr, July 1, 2007; 31(4): 295 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Storey The Role of Oral Glutamine in Pediatric Bone Marrow Transplant Journal of Pediatric Oncology Nursing, January 1, 2007; 24(1): 41 - 45. [Abstract] [PDF]
|
|
|
|
|
|
M. Richardson, L. Martel, and L. Martensson Outpatient Transfusion Practice and Factors Leading to Inpatient Transfusion in a Pediatric Hematology/Oncology Program Journal of Pediatric Oncology Nursing, January 1, 2007; 24(1): 46 - 51. [Abstract] [PDF]
|
|
|
|
|
|
Y. Hastings, M. White, and J. Young Enteral Nutrition and Bone Marrow Transplantation Journal of Pediatric Oncology Nursing, March 1, 2006; 23(2): 103 - 110. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Roberts and J. Thompson Graft-vs-Host Disease: Nutrition Therapy in a Challenging Condition Nutr Clin Pract, August 1, 2005; 20(4): 440 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hockenberry Symptom Management Research in Children With Cancer Journal of Pediatric Oncology Nursing, May 1, 2004; 21(3): 132 - 136. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Duggan, L. Bechard, K. Donovan, M. Vangel, A. O'Leary, C. Holmes, L. Lehmann, and E. Guinan Changes in resting energy expenditure among children undergoing allogeneic stem cell transplantation Am. J. Clinical Nutrition, July 1, 2003; 78(1): 104 - 109. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
